22.418 articles found

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE

SCHENK DALE B, MASLIAH ELIEZER, GAMES KATE DORA, CHILCOTE TAMIE J, ROCKENSTEIN EDWARD, BUTTINI MANUEL J.

· 2008-02-22

Pallidal burst activity during therapeutic deep brain stimulation.

Hahn PJ, Russo GS, Hashimoto T, Miocinovic S, Xu W, McIntyre CC, Vitek JL.

Exp Neurol · 2008-02-20

DOI: 10.1016/j.expneurol.2008.01.032PMID: 18355810

Subthalamic nucleus stimulation and levodopa-resistant postural instability in Parkinson's disease.

Visser JE, Allum JH, Carpenter MG, Esselink RA, Speelman JD, Borm GF, Bloem BR.

J Neurol · 2008-02-18

DOI: 10.1007/s00415-008-0636-xPMID: 18274810

Long-term retention rate of entacapone in the treatment of Parkinson's disease.

Keränen T, Tuhkasaari M, Kuusisto H.

Eur J Neurol · 2008-02-16

DOI: 10.1111/j.1468-1331.2008.02068.xPMID: 18284429

Interaction between levodopa and enteral nutrition.

Cooper MK, Brock DG, McDaniel CM.

Ann Pharmacother · 2008-02-13

DOI: 10.1345/aph.1k450PMID: 18272698

Parkinson's disease: levodopa-induced dyskinesia and signal transduction.

Santini E, Valjent E, Fisone G.

FEBS J · 2008-02-12

DOI: 10.1111/j.1742-4658.2008.06296.xPMID: 18279379

Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion.

Sydow O.

FEBS J · 2008-02-12

DOI: 10.1111/j.1742-4658.2008.06295.xPMID: 18279380

Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.

Nehru B, Verma R, Khanna P, Sharma SK.

Brain Res · 2008-02-09

DOI: 10.1016/j.brainres.2008.01.074PMID: 18308296

Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease.

Brooks DJ, Leinonen M, Kuoppamäki M, Nissinen H.

J Neural Transm (Vienna) · 2008-02-08

DOI: 10.1007/s00702-008-0025-8PMID: 18259682

1,5-DIARYL-PYRAZOLES AS CANNABINOID RECEPTOR NEUTRAL ANTAGONISTS USEFUL AS THERAPEUTIC AGENTS

GREIG IAIN ROBERT, ROSS RUTH ALEXANDRA, PERTWEE ROGER GUY.

· 2008-02-07

1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents

GREIG IAIN ROBERT, ROSS RUTH ALEXANDRA, PERTWEE ROGER GUY.

· 2008-02-07

Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism.

Zhang X, Andren PE, Greengard P, Svenningsson P.

Proc Natl Acad Sci U S A · 2008-02-06

DOI: 10.1073/pnas.0711839105PMID: 18256188